从脂肪组织中心视角看非酒精性脂肪性肝病的发生与进展
本文综述白色脂肪组织功能障碍在非酒精性脂肪性肝病发生和进展中的作用。脂肪组织超过个体化肥胖阈值后储存脂质功能失调,引发代谢不灵活、炎症和脂肪因子分泌异常,导致肝脏脂质过载,从单纯性脂肪肝进展为脂肪性肝炎、肝硬化和肝细胞癌。
要点
- 白色脂肪组织与肝脏协同调控全身能量稳态,脂肪组织超过个体化肥胖阈值后功能失调。
- 脂肪组织储存和动员脂质失败导致全身脂质过载,尤其肝脏脂质过载。
- 肥胖诱导的脂肪组织功能障碍在非酒精性脂肪性肝病进展中具有致病重要性。
核心结论
- 肥胖诱导的脂肪组织功能障碍,即脂肪储存能力和代谢灵活性下降,在非酒精性脂肪肝和非酒精性脂肪性肝炎的发生和进展中具有致病重要性。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- 脂肪组织在超过个体化肥胖阈值后储存脂质功能失调,导致代谢不灵活、进行性炎症和脂肪因子分泌异常。
- 脂肪组织无法储存和动员脂质导致全身脂质过载,尤其肝脏;肝脏脂质过载来源包括脂肪组织释放的脂质、膳食脂肪摄入和增强的从头脂肪酶合成。
- 肝外代偿机制包括棕色脂肪组织氧化多余脂肪酸和白色脂肪组织以甘油三酯形式储存脂肪酸。
- 上述稳态机制失败导致肝脏脂质组数量增加和性质改变,肝细胞优先积累甘油三酯,初期为相对良性的非酒精性脂肪肝。
- 随时间推移出现炎症反应,部分个体进展为更严重情况如非酒精性脂肪性肝炎、肝硬化和肝细胞癌,常无早期预后线索。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alongside the liver, white adipose tissue (WAT) is critical in regulating systemic energy homeostasis. Although each organ has its specialised functions, they must work coordinately to regulate whole-body metabolism. Adipose tissues and the liver are relatively resilient and can adapt to an energy surplus by facilitating triglyceride (TG) storage up to a certain threshold level without significant metabolic disturbances. However, lipid storage in WAT beyond a "personalised" adiposity threshold becomes dysfunctional, leading to metabolic inflexibility, progressive inflammation, and aberrant adipokine secretion. Moreover, the failure of adipose tissue to store and mobilise lipids results in systemic knock-on lipid overload, particularly in the liver. Factors contributing to hepatic lipid overload include lipids released from WAT, dietary fat intake, and enhanced de novo lipogenesis. In contrast, extrahepatic mechanisms counteracting toxic hepatic lipid overload entail coordinated compensation through oxidation of surplus fatty acids in brown adipose tissue and storage of fatty acids as TGs in WAT. Failure of these integrated homeostatic mechanisms leads to quantitative increases and qualitative alterations to the lipidome of the liver. Initially, hepatocytes preferentially accumulate TG species leading to a relatively "benign" non-alcoholic fatty liver. However, with time, inflammatory responses ensue, progressing into more severe conditions such as non-alcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma, in some individuals (often without an early prognostic clue). Herein, we highlight the pathogenic importance of obesity-induced "adipose tissue failure", resulting in decreased adipose tissue functionality (i.e. fat storage capacity and metabolic flexibility), in the development and progression of NAFL/NASH.
引用
- Lee E, Korf H, Vidal-Puig A, et al. An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease. J Hepatol. 2023. PMID: 36740049. doi:10.1016/j.jhep.2023.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。